Open innovation for new drug research in Indian pharmaceutical sector

Tools

Bhatnagar, Bhawani and MacBryde, Jillian and Dörfler, Viktor (2014) Open innovation for new drug research in Indian pharmaceutical sector. In: Drug Discovery India 2014, 2014-09-11 - 2014-09-12, Ramada Powai Hotel & Convention Centre.

[thumbnail of Bhatnagar-etal-DDI2014-open-innovation-for-new-drug-research]
Preview
 Text. Filename: Bhatnagar_etal_DDI2014_open_innovation_for_new_drug_research.pdf
Accepted Author Manuscript
Download (526kB)| Preview

Abstract

The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

ORCID iDs

Bhatnagar, Bhawani ORCID logoORCID: https://orcid.org/0000-0003-0220-1052, MacBryde, Jillian ORCID logoORCID: https://orcid.org/0000-0002-8624-6989 and Dörfler, Viktor ORCID logoORCID: https://orcid.org/0000-0001-8314-4162;
CORE (COnnecting REpositories)